Kazatomprom’s Sulfuric Acid Gap: a Structural Risk for Uranium

A construction crew building the plant that was supposed to insulate the world’s largest uranium producer from its most stubborn supply risk found something that stopped them cold: fossilised bones in the earthworks.

That discovery, at the site of Kazatomprom’s third sulfuric acid plant, has done more than pause a construction project. It has handed an already-stretched supply chain a fresh variable with a tail of six to twelve months, and possibly longer.

Kazatomprom mines uranium almost entirely through in-situ recovery (ISR), a method that cannot operate without a continuous, high-volume flow of sulfuric acid. The Taiqonyr Qyshqyl Zauyty (TQZ) plant was the company’s primary route to cutting its dependence on externally sourced acid. The delay now pushes that dependence into late 2027 or early 2028, precisely as acid costs are climbing at roughly 40% a year and a temporary Russian export ban on sulfuric acid runs to 31 December 2026.

For anyone tracking the company’s cost structure or forward production, this is the moment to look closely. Three variables now govern the outlook: cost inflation, volume risk, and what both mean for uranium pricing.

How a paleontological find became an operational risk event

Fossilised remains turning up at an industrial construction site sounds like a footnote. It is not.

When the project contractor uncovered paleontological specimens during earthworks at one of the TQZ sites, construction in the affected zone stopped immediately. That halt was not a management decision open to negotiation. Under Kazakhstan’s law on national historical and cultural heritage, the discovery triggered a mandatory regulatory process: specialised excavations to recover the specimens, laboratory analysis, and a formal determination by the authorities before work can resume.

Kazakhstan’s regulatory framework for critical minerals operates alongside heritage protection law, and the state’s expanding control over subsoil assets introduces a layer of sovereign policy risk that sits beneath both the excavation timeline and the acid procurement question.

Kazakhstan’s heritage law on archaeological examination mandates a formal excavation, laboratory analysis, and regulatory determination before industrial construction can resume, with administrative liability including work suspension applying to any project that proceeds without completing the process.

The outcome now depends on what the excavation finds, and there are two paths.

• Single specimen confirmed: Removal of the remains and resumption of construction are anticipated, keeping the delay within the disclosed range.
• Larger group or expanded excavation zone identified: Infrastructure may need to be redesigned and relocated, which would extend the timeline and add cost beyond the current estimate.

That fork is the operative uncertainty. Investors cannot price this as a fixed delay, because the outcome hinges on findings that are still pending. The six-to-twelve month window could widen.

Kazatomprom disclosed the delay officially in its 1H 2026 IFRS financial statements, shifting the commissioning window from the end of Q1 2027 to a range of Q3 2027 to Q1 2028.

Company filings reference the halt as a consequence of “potential paleontological specimens” discovered during construction, with the commissioning date revised accordingly. Official disclosures stop short of naming the species or age of the remains.

The scale of what is being delayed matters. TQZ is designed to produce roughly 800,000 tonnes per year of sulfuric acid, at a total project cost of approximately 113 billion tenge, of which 85 billion tenge comes from loan financing provided by the Development Bank of Kazakhstan.

The discovery is unusual. The mechanism is not. Kazakhstan’s heritage law converts any qualifying find into a regulatory process with no guaranteed end date. The sensible read is to treat Q3 2027 to Q1 2028 as a floor, not a midpoint.

The acid dependency Kazatomprom cannot route around

To understand why an acid plant delay registers as a cost event rather than an engineering inconvenience, you have to understand how ISR works.

In-situ recovery does not dig ore out of the ground. It circulates a leaching solution through uranium-bearing aquifers using a grid of injection and production wells. That solution contains sulfuric acid, which dissolves the uranium in the host rock so it can be pumped to the surface. The process runs continuously, and it stops working the moment the acid supply falters. The wells cannot hold the flow rate or the chemical conditions the method depends on.

That makes acid a non-negotiable input, not a variable one. And ISR is thirsty for it: producing one kilogram of uranium consumes 75 to 95 kg of sulfuric acid. Scaled to Kazatomprom’s output, that implies an annual acid requirement of roughly 1.8 to 2.2 million tonnes.

Securing incremental volumes is structurally difficult, which is the subject of the next point. First, the cost trajectory.

Read that column of increases as a compounding trajectory, not a run of one-off jumps. Costs have risen more than 100% over three years, and the estimated 39% rise into 2026 builds on an already elevated base.

Kazatomprom’s own figures put acid at 15.3% of production costs for 2026. Independent analysts see it differently.

Independent analysts estimate that at full scale, sulfuric acid accounts for 18-22% of Kazatomprom’s operational costs, well above the company’s stated share.

That gap is not a rounding difference. It signals that investors relying solely on company disclosures may be underpricing the acid drag on margins, especially with the Russian export ban restricting a channel that cannot be replaced domestically at short notice. Russia supplied 93.6% of Kazakhstan’s sulfuric acid imports in 2023, and its temporary export ban runs to 31 December 2026. Without TQZ operational, analysts estimate Kazatomprom must buy around 1.5 million tonnes per year externally.

Every month TQZ is delayed is a month of buying acid on a market where prices have more than doubled in three years, through an import channel facing a policy-driven cutoff. That is the mechanism turning an engineering setback into a margin story.

Why the spot market cannot absorb Kazatomprom’s shortfall

Sulfuric acid is not manufactured to order the way a dedicated chemical input is. It is predominantly a by-product of smelting and industrial processes, which means supply cannot simply scale up in response to a demand signal.

Competing demand compounds the problem. Fertiliser, chemicals, and metals producers all draw on the same pool, so any incremental volume a uranium producer wants is contested and priced at a premium. For Kazatomprom, that is exactly why the shortfall cannot be papered over with spot purchases at reasonable cost.

Sulfuric acid supply dynamics extend well beyond uranium: record sulphur prices have reshaped procurement strategies across copper, nickel, and fertiliser production simultaneously, which is precisely why incremental spot volumes for ISR operations carry a structural premium that spot price quotes alone do not capture.

Production guidance revisions and what they signal about operational headroom

Look at Kazatomprom’s guidance history over the past two years and a pattern emerges. This is not a series of isolated adjustments. It is a stepwise retreat, each step acknowledging the same underlying constraint in the company’s own numbers.

The sequence is worth laying out in order.

1. Original 2025 target: 30,500-31,500 tU (100% basis).
2. Revised 2025 target (August 2024): 25,000-26,500 tU (100% basis).
3. Actual 2025 output: 25,839 tU (100% basis), or 67.18 million pounds U3O8.
4. 2026 guidance: 27,500-29,000 tU (100% basis), or 71.49-75.39 million pounds U3O8.
5. Gap versus earlier 2026 ambition: roughly 8 million pounds U3O8 removed from what was once targeted at approximately 32,777 tU.

Management attributes the scale-back to market conditions, project bottlenecks, and its option to operate within a 20% deviation of subsoil use production levels. Strip that back to what it means, and the 8-million-pound reduction is not a demand-side call. It is a reagent-constrained ceiling.

The risk to 2027 sharpens the point. If the Russian acid export ban is not exempted by an intergovernmental agreement, analysts estimate Kazatomprom’s 2027 production could fall by roughly 3 million pounds, about 4%. That is measurable and specific, not speculative.

Here is the part investors should sit with. Even after TQZ commissions, the 800,000-tonne plant covers only a slice of an annual requirement of 1.8 to 2.2 million tonnes. TQZ reduces the structural dependency. It does not eliminate it. The forward guidance range should be treated as a reagent-constrained ceiling, not a conservative number with hidden upside.

What Kazatomprom’s supply constraints mean for uranium pricing and long-term contracts

Widen the frame from Kazatomprom’s cost sheet to the market it sits at the centre of, and the picture changes shape. The company’s constraints do not just squeeze its own margins. They function as a structural price support for the entire uranium market.

Kazatomprom accounts for over 40% of global mined uranium. When a producer of that scale trims output for reasons it cannot quickly fix, the shortfall behaves like a floor under spot and term prices rather than a passing dip. Its growing book of long-term, state-linked supply agreements compounds the effect by pulling liquidity out of the spot market, which magnifies the price impact of any future disruption.

Uranium supply chain disruptions emanating from Kazakhstan interact with concurrent pressure points elsewhere in the nuclear fuel cycle, including conversion and enrichment bottlenecks, meaning the market’s response to Kazatomprom news flow reflects compounding constraints rather than a single-source shock.

Utility buyers have already absorbed the lesson. Procurement horizons have stretched from the traditional 3-5 year cycles to 7-10 year cycles, and buyers are now accepting scarcity premiums of 20-30% over spot to secure supply.

That premium acceptance is the tell. It means the market is not waiting for TQZ to be resolved before acting. Recent contracts underline how far the behaviour has shifted: India’s 9-year agreement with Cameco for 22 million pounds covering 2027-2035, and Google’s 22-year deal for output from Fortum’s Loviisa reactor.

Permitting problems in Niger, combined with the Kazatomprom disruptions, pushed spot uranium to a six-month high of $89.50 per pound, with term prices surging roughly 23%.

For investors, the three risk categories worth holding in view are these:

• Cost inflation: the sulfuric acid price trajectory, still running near 40% annually into 2026, feeding directly into C1 cash costs and all-in sustaining costs.
• Volume risk: production guidance exposure, with a reagent-constrained ceiling and a specific 3-million-pound downside if the Russian ban bites in 2027.
• Market pricing implications: spot and term dynamics that already respond to Kazatomprom news flow.

There is a counterweight worth noting. Some analysts caution that reactor construction remains subject to regulatory, financing, and policy hurdles, so demand growth may be uneven and lag the ambitious capacity targets driving the bullish narrative.

The concrete date to circle is 31 December 2026. If the Russian ban is not renewed or exempted, the supply disruption converts into a 2027 production impact of roughly 3 million pounds, moving guidance and pricing at the same time.

What the TQZ timeline means for investors positioned in uranium

Pull the threads together and the analysis resolves into a monitoring framework rather than a verdict. Three variables determine whether the TQZ delay stays inside its six-to-twelve month range or runs longer.

The first is the excavation outcome. A single specimen keeps the timeline on track; a larger group or expanded dig zone raises the prospect of redesign and relocation, which would lift both cost and duration. The second is the Russian export ban at 31 December 2026. The third is Kazatomprom’s ability to secure incremental external acid at manageable cost while it waits.

Treat that commissioning window as a floor with extension risk in one direction only. There is no realistic path to earlier completion, but several to a later one.

Resource nationalism risk in Kazakhstan’s uranium sector has accelerated alongside the regulatory changes affecting foreign partners, adding a political dimension to the acid supply and excavation timeline uncertainties that investors in Kazatomprom or its joint venture counterparts need to hold alongside the operational analysis.

The distinction that matters most is between what TQZ resolves and what it leaves untouched.

• What TQZ covers: roughly 800,000 tonnes per year of internal acid supply, cutting external procurement dependency by that amount.
• What remains externally sourced: approximately 1.0 to 1.4 million tonnes per year, still purchased in a structurally inflationary market.

Management’s 20% deviation flexibility on subsoil use production levels provides a buffer, but it does not remove the constraint. TQZ commissioning is necessary but not sufficient to close the acid vulnerability. The residual gap, not the headline commissioning date, is the reference point for positioning decisions.

Three variables, one floor: positioning around Kazatomprom’s constrained outlook

The constraints here are structural, not episodic. Cost inflation, volume risk, and market pricing all trace back to the same root: an ISR production model that runs on acid Kazatomprom cannot yet produce for itself in sufficient volume. TQZ improves that position. It does not resolve it.

That has a forward implication worth stating plainly. As the world’s largest producer, at over 40% of global mined supply, operates below its potential output ceiling for reagent-related reasons, the structural floor under spot and term uranium prices rests on more than the demand-side story of nuclear expansion. Supply-side constraint is doing real work.

The practical posture is asymmetric. The downside scenarios, an expanded excavation, a Russian ban extension, continued acid cost inflation, are more numerous and more proximate than the single upside case where TQZ commissions on time and Russian acid resumes flowing.

For investors, that means monitoring the triggers rather than waiting for resolution:

• Watch the excavation regulatory determination, which sets whether the delay holds within range or extends.
• Track the Russian export ban status ahead of 31 December 2026.
• Assess each production guidance update against the residual acid procurement gap, not against the TQZ commissioning date alone.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors, and forward-looking statements are speculative and subject to change based on market developments and company performance.